Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Transposable elements as a possible missing link between genetic predisposition and environmental triggers of autoimmune disorders : insights from type 1 diabetes, systemic lupus erythematosus and rheumatoid arthritis
Authors:ID Mužina, Karolina (Author)
ID Markež, Ana (Author)
ID Jenko Bizjan, Barbara (Author)
ID Šamec, Neja (Author)
ID Kovač, Jernej (Author)
ID Dovč, Klemen (Author)
ID Battelino, Tadej (Author)
ID Pokorn, Marko (Author)
Files:.pdf PDF - Presentation file, download (2,12 MB)
MD5: 9305FDC3E136FAF46C65554CA2834F71
 
URL URL - Source URL, visit https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1774863/full
 
Language:English
Typology:1.02 - Review Article
Organization:Logo UKC LJ - Ljubljana University Medical Centre
Abstract:Transposable elements (TEs) make up almost half of the human genome and are among its most densely methylated regions. Their epigenetic silencing is crucial for genomic stability and immune homeostasis, and accumulating evidence indicates that dysregulated TE methylation and expression contribute to autoimmune disease pathogenesis. Hypomethylation of selected TE families can permit transcriptional reactivation, production of immunostimulatory nucleic acids and peptides, and engagement of pattern-recognition receptors, thereby driving type I interferon (IFN-I) signaling through “viral mimicry”–like mechanisms. In parallel, TE-derived enhancers, promoters and exons reshape gene regulatory networks at immune loci. In this narrative review, we synthesize current knowledge on TE methylation and expression in autoimmunity, with a focus on type 1 diabetes (T1D), systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). We first outline TE biology and the principal mechanisms of epigenetic silencing, then summarise methodological advances for TE methylation and expression profiling, including long-read sequencing and TE-aware RNA-seq pipelines. We next dissect disease-specific evidence: longitudinal epigenomic studies in T1D showing preclinical DNA methylation changes and altered Alu/LINE-1 patterns, together with HERV-H/W upregulation at onset, SLE studies demonstrating LINE-1 hypomethylation in neutrophils and cell-type–specific TE overexpression that tracks with IFN signatures and nucleic acid sensor pathways, and RA studies linking global and LINE-1 methylation to methotrexate response when integrated with serostatus. Across conditions, TE methylation behaves more like a relatively stable disease-associated trait than a simple activity marker and exhibits clear disease- and cell-type-specific signatures rather than global hypomethylation. We conclude that TEs are not passive genomic relics but epigenetically regulated elements that can act as endogenous sources of immunostimulatory nucleic acids, neoantigens and regulatory sequences, providing a mechanistic bridge between genetic susceptibility and environmental triggers in autoimmunity. Consequently, selective dysregulation of TE methylation and expression offers both an explanatory framework for interferon-driven autoimmunity and a promising, currently underused layer for biomarker development and therapeutic targeting.
Keywords:RNA-seq, autoimmune disease, autoimmunity, epigenetic, methylation, sequencing, transposable elements
Publication status:Published
Publication version:Version of Record
Year of publishing:2026
Number of pages:str. 1-19
Numbering:Vol. 17, [article no.] 1774863
PID:20.500.12556/DiRROS-31961 New window
UDC:61:575
ISSN on article:1664-3224
DOI:10.3389/fimmu.2026.1774863 New window
COBISS.SI-ID:288321795 New window
Note:Nasl. z nasl. zaslona; Opis vira z dne 20. 8. 2026;
Publication date in DiRROS:20.08.2026
Views:71
Downloads:46
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Frontiers in immunology
Shortened title:Front. immunol.
Publisher:Frontiers Research Foundation
ISSN:1664-3224
COBISS.SI-ID:30774233 New window

Document is financed by a project

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:P3-0343-2022
Name:Etiologija, zgodnje odkrivanje in zdravljenje bolezni pri otrocih in mladostnikih

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J7-60116-2025
Name:Slovenski referenčni genomski projekt

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-50115-2023
Name:Odkrivanje spremenjenih regulatornih poti, epigenetskih sprememb in prirojenih genetskih variant pri otroškem multisistemskem vnetnem sindromu povezanem s COVID-19

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-50122-2023
Name:Genomsko presejanje novorojenčkov

Funder:ARIS - Slovenian Research and Innovation Agency
Project number:J3-4521-2022
Name:Endogeni virusni elementi v patogenezi sladkorne bolezni tipa 1

Licences

License:CC BY 4.0, Creative Commons Attribution 4.0 International
Link:http://creativecommons.org/licenses/by/4.0/
Description:This is the standard Creative Commons license that gives others maximum freedom to do what they want with the work as long as they credit the author.

Back